
No sooner said than done.
Following the announcement that David Solomon would be leaving Denmark-based biotech Zealand Pharma, the departing CEO told MedWatch that he would be back in an executive role, and he has now made good on that promise.
Allerede abonnent? Log ind.
Læs hele artiklen
Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app